Plasma pharmacokinetics of high dose oral versus intravenous rifampicin in patients with tuberculous meningitis: a randomized controlled trial
View ORCID ProfileSean Wasserman, Angharad Davis, Cari Stek, Maxwell Chirehwa, Stephani Botha, Remy Daroowala, Marise Bremer, Mpumi Maxebengula, Sonya Koekemoer, Rene Goliath, Amanda Jackson, Thomas Crede, Jonathan Naude, Patryk Szymanski, Yakoob Vallie, Muhammed S Moosa, View ORCID ProfileLubbe Wiesner, John Black, Graeme Meintjes, View ORCID ProfileGary Maartens, Robert J Wilkinson
doi: https://doi.org/10.1101/2021.02.11.21250624
Sean Wasserman
1Wellcome Centre for Infectious Diseases Research in Africa, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, South Africa
2Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Observatory, 7925, South Africa
Angharad Davis
1Wellcome Centre for Infectious Diseases Research in Africa, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, South Africa
3Francis Crick Institute, Midland Road, London, NW11AT, UK
4Faculty of Life Sciences, University College London, Gower Street, London, WC1E 6BT, UK
Cari Stek
1Wellcome Centre for Infectious Diseases Research in Africa, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, South Africa
5Department of Infectious Diseases, Imperial College, London, W12ONN, UK
6Department of Medicine, University of Cape Town, Cape Town, South Africa
Maxwell Chirehwa
7Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory, 7925, South Africa
Stephani Botha
1Wellcome Centre for Infectious Diseases Research in Africa, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, South Africa
Remy Daroowala
1Wellcome Centre for Infectious Diseases Research in Africa, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, South Africa
5Department of Infectious Diseases, Imperial College, London, W12ONN, UK
Marise Bremer
1Wellcome Centre for Infectious Diseases Research in Africa, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, South Africa
8Livingstone Hospital Complex, Eastern Cape Department of Health, Port Elizabeth, South Africa
Mpumi Maxebengula
1Wellcome Centre for Infectious Diseases Research in Africa, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, South Africa
Sonya Koekemoer
1Wellcome Centre for Infectious Diseases Research in Africa, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, South Africa
Rene Goliath
1Wellcome Centre for Infectious Diseases Research in Africa, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, South Africa
Amanda Jackson
1Wellcome Centre for Infectious Diseases Research in Africa, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, South Africa
Thomas Crede
6Department of Medicine, University of Cape Town, Cape Town, South Africa
9Mitchells Plain Hospital, Western Cape Department of Health, Cape Town, South Africa
Jonathan Naude
6Department of Medicine, University of Cape Town, Cape Town, South Africa
9Mitchells Plain Hospital, Western Cape Department of Health, Cape Town, South Africa
Patryk Szymanski
6Department of Medicine, University of Cape Town, Cape Town, South Africa
9Mitchells Plain Hospital, Western Cape Department of Health, Cape Town, South Africa
Yakoob Vallie
6Department of Medicine, University of Cape Town, Cape Town, South Africa
10New Somerset Hospital, Western Cape Department of Health, Cape Town, South Africa
Muhammed S Moosa
6Department of Medicine, University of Cape Town, Cape Town, South Africa
10New Somerset Hospital, Western Cape Department of Health, Cape Town, South Africa
Lubbe Wiesner
7Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory, 7925, South Africa
John Black
8Livingstone Hospital Complex, Eastern Cape Department of Health, Port Elizabeth, South Africa
Graeme Meintjes
1Wellcome Centre for Infectious Diseases Research in Africa, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, South Africa
2Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Observatory, 7925, South Africa
Gary Maartens
1Wellcome Centre for Infectious Diseases Research in Africa, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, South Africa
7Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory, 7925, South Africa
Robert J Wilkinson
1Wellcome Centre for Infectious Diseases Research in Africa, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, South Africa
2Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Observatory, 7925, South Africa
3Francis Crick Institute, Midland Road, London, NW11AT, UK
4Faculty of Life Sciences, University College London, Gower Street, London, WC1E 6BT, UK
5Department of Infectious Diseases, Imperial College, London, W12ONN, UK
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted February 12, 2021.
Plasma pharmacokinetics of high dose oral versus intravenous rifampicin in patients with tuberculous meningitis: a randomized controlled trial
Sean Wasserman, Angharad Davis, Cari Stek, Maxwell Chirehwa, Stephani Botha, Remy Daroowala, Marise Bremer, Mpumi Maxebengula, Sonya Koekemoer, Rene Goliath, Amanda Jackson, Thomas Crede, Jonathan Naude, Patryk Szymanski, Yakoob Vallie, Muhammed S Moosa, Lubbe Wiesner, John Black, Graeme Meintjes, Gary Maartens, Robert J Wilkinson
medRxiv 2021.02.11.21250624; doi: https://doi.org/10.1101/2021.02.11.21250624
Plasma pharmacokinetics of high dose oral versus intravenous rifampicin in patients with tuberculous meningitis: a randomized controlled trial
Sean Wasserman, Angharad Davis, Cari Stek, Maxwell Chirehwa, Stephani Botha, Remy Daroowala, Marise Bremer, Mpumi Maxebengula, Sonya Koekemoer, Rene Goliath, Amanda Jackson, Thomas Crede, Jonathan Naude, Patryk Szymanski, Yakoob Vallie, Muhammed S Moosa, Lubbe Wiesner, John Black, Graeme Meintjes, Gary Maartens, Robert J Wilkinson
medRxiv 2021.02.11.21250624; doi: https://doi.org/10.1101/2021.02.11.21250624
Subject Area
Subject Areas
- Addiction Medicine (347)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2637)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12211)
- Forensic Medicine (10)
- Gastroenterology (758)
- Genetic and Genomic Medicine (4087)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2645)
- Health Policy (1003)
- Hematology (362)
- HIV/AIDS (850)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3862)
- Nursing (209)
- Nutrition (577)
- Oncology (2022)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6516)
- Radiology and Imaging (1398)
- Respiratory Medicine (871)
- Rheumatology (404)
- Sports Medicine (342)
- Surgery (444)
- Toxicology (52)
- Transplantation (185)
- Urology (165)